Nektar Therapeutics Securities Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Nektar Therapeutics · Securities · New Filing
Last updated
Case overview
- Defendant company
- Nektar Therapeutics
- Product or service
- Securities
- Case status
- New Filing
- Lawsuit type
- Securities
Participation information
Availability is based on each listed participation option and its deadline.
Investor Legal Rights Consultation
Investors who purchased or acquired Nektar securities between February 26, 2025 and December 15, 2025 may contact the law firm to discuss their legal rights.
Call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato at (212) 355-4648, or use the article's participation link.
- Type
- Law Firm Signup
- Status
- Unknown
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.